"Dr. Maurizio Scarpa, President of the Brains for Brain Foundation stated, "The study that we have recently performed in collaboration with biOasis produced some exciting data. I am very encouraged that after some adjustments regarding dosing, we might be able to move this program into the clinic. My goal and I am sure the goal of biOasis as well, is to help children with this devastating disease. I am very encouraged that based on these results, Transcend may play an important role in helping us achieve our goals.""

This is such a positive statement coming from a leader in the Lysosomal Storage Disease field. Fantastic news release today!

Enzymes across the BBB, check. Antibodies across the BBB, check. siRNA across the BBB, check. Great days ahead for Bioasis and Transcendpep!